1 Part 3 Interpretation and Clinical Use of 1,5-Anhydroglucitol Values An Educational Service from G...

10
1 Part 3 Interpretation and Clinical Use of 1,5-Anhydroglucitol Values An Educational Service from GLYCOMARK GLYCOMARK is a registered trademark of GlycoMark, Inc. © GlycoMark, Inc. All rights reserved NOTE: Please see slide notes below each page for study and slide details

Transcript of 1 Part 3 Interpretation and Clinical Use of 1,5-Anhydroglucitol Values An Educational Service from G...

Page 1: 1 Part 3 Interpretation and Clinical Use of 1,5-Anhydroglucitol Values An Educational Service from G LYCO M ARK G LYCO M ARK is a registered trademark.

1

Part 3 Interpretation and Clinical Use of 1,5-Anhydroglucitol Values

An Educational Service from GLYCOMARK

GLYCOMARK is a registered trademark of GlycoMark, Inc.© GlycoMark, Inc. All rights reserved

NOTE: Please see slide notes below each page for study and slide details

Page 2: 1 Part 3 Interpretation and Clinical Use of 1,5-Anhydroglucitol Values An Educational Service from G LYCO M ARK G LYCO M ARK is a registered trademark.

2

GLYCOMARK 1,5-AG Value Correlation toEstimated Average Peak Glucose (eAPG)

• When A1C > 8%, 1,5-AG will almost always be <10 µg/mL due to 1,5-AG tissue depletion from constant hyperglycemic state

• When A1C < 8%, 1,5-AG reveals differences in postprandial glucose

Dungan, K., Buse, J. et al. Diabetes Care, June 2006Patent No. US 8,178,312 B2 May 15, 2012

Page 3: 1 Part 3 Interpretation and Clinical Use of 1,5-Anhydroglucitol Values An Educational Service from G LYCO M ARK G LYCO M ARK is a registered trademark.

3

Actual Clinical Data

A1Cs <7.0%Meet ADA Guidelines

Similar A1Cs can have very different postmeal glucoses

Actual patient results from Diabetes Care Center, Hudson, FL and other paired lab results

A1C

1,5-AG Paired Value

Estimated Average Peak Glucose

(eAPG)

8.3 %8.17.97.87.77.5

2.7 µg/mL5.14.43.56.5

19.6

258 mg/dL211219235199171

7.47.4

15.13.4

175237

7.27.2

19.25.7

171205

7.07.0

18.12.0

172294

6.86.86.7

20.85.84.4

170204219

6.46.46.4

16.86.32.3

173200276

6.36.36.3

10.29.24.3

184187221

5.75.7

23.24.9

169213

1,5-AG identifies patients at higher risk so you can make needed

therapy changes

Low 1,5-AG values with low A1Cs may reveal

undetected hypoglycemia

Page 4: 1 Part 3 Interpretation and Clinical Use of 1,5-Anhydroglucitol Values An Educational Service from G LYCO M ARK G LYCO M ARK is a registered trademark.

4

Glycemic Blood Marker Comparison

• 1,5-Anhydroglucitol reflects recent glycemic variability not detected by A1C – Measures therapy change effectiveness in 2-4 weeks– Detects glycemic deterioration or improvement earlier

123456789101112131415 0

1,5-AG

Fructosamine orGlycated Albumin

HbA1C

Weeks Prior to Measurement

FBG or SMBG

Page 5: 1 Part 3 Interpretation and Clinical Use of 1,5-Anhydroglucitol Values An Educational Service from G LYCO M ARK G LYCO M ARK is a registered trademark.

5

When patients have low 1,5-AG values, consider further assessment…

• Anything unusual in the past 2 weeks?– Vacation/holiday – unusual food intake– Stopped taking diabetes medication – Steroid injection– Illness or unusual stress

• Consider…– Structured postmeal fingerstick glucose testing – 24 hour glucose profile – 3-day continuous glucose monitor

Page 6: 1 Part 3 Interpretation and Clinical Use of 1,5-Anhydroglucitol Values An Educational Service from G LYCO M ARK G LYCO M ARK is a registered trademark.

6

Limitations of 1,5-Anhydroglucitol Test

• Low values have been observed in– Advanced kidney disease Stage 4 or 5; < 30 GFR; Dialysis– Cirrhosis of the liver Reduced 1,5-AG liver biosynthesis– Pregnancy Due to low and varying renal thresholds– Drugs

• Acarbose Reduces absorption of carbs including 1,5-AG• SGLT2 inhibitors Effect unknown (1,5-AG is transported via SGLT4)

• High values have been observed in– Some IV hyperalimentation solutions– Some Chinese medicines (Polygala, Tenuifolia, Senega Syrup)

Page 7: 1 Part 3 Interpretation and Clinical Use of 1,5-Anhydroglucitol Values An Educational Service from G LYCO M ARK G LYCO M ARK is a registered trademark.

Suggested Personalized Therapy Algorithm

Modified from Dungan.Expert Rev Mol Diagn 8(1), 2008Patent No. US 8,178,312 B2 May 15 2012

Identify hidden PPH Monitor therapy changes

Page 8: 1 Part 3 Interpretation and Clinical Use of 1,5-Anhydroglucitol Values An Educational Service from G LYCO M ARK G LYCO M ARK is a registered trademark.

8

1,5-AG Assay Summary

• Clinically proven two week measure of glucose spikes1,2,3 – Detects recent deterioration in glucose control missed by A1C – Assesses therapy effectiveness after change4

– Reinforces positive adherence to therapy and lifestyle changes4

• Guides selection of the right medication to improve A1Cs while potentially reducing risk of hypoglycemia– Fasting vs. prandial glucose– Identify patients who need more frequent SBGM or CGM – Appropriate selection of more costly prandial or injectable drugs

1 Wang, et al., Diabetes Metab Res Rev 2012; 28: 357–362.2 Dungan, K., Buse, J. et al. Diabetes Care, June 20063 Yamanouchi, et al. Clin Sci (Lond) 2001 Sep;101(3):227-33.4 McGill, et al, Diabetes Care, Vol 27, No. 8, August 2004

Page 9: 1 Part 3 Interpretation and Clinical Use of 1,5-Anhydroglucitol Values An Educational Service from G LYCO M ARK G LYCO M ARK is a registered trademark.

9

The Glycemic Triad Diabetes Panel

1,5-AnhydroglucitolPostprandial hyperglycemia marker

(Last 14 days)

Average glucose marker(Last 60-90 days)

Fasting GlucoseBaseline glucose marker(Current point in time)

HbA1C

Page 10: 1 Part 3 Interpretation and Clinical Use of 1,5-Anhydroglucitol Values An Educational Service from G LYCO M ARK G LYCO M ARK is a registered trademark.

10

For more information

• For a listing of postprandial hyperglycemia outcome studies, please visit www.glycomark.com/postprandialhyperglycemia

• For a listing of studies about the 1,5-anhydroglucitol biomarker for postprandial hyperglycemia, please visit www.glycomark.com/product/studies

• For a 3-minute overview about the 1,5-anhydroglucitol biomarker, please visit www.glycomark.com/movie